STAT

3 issues to watch in global health in 2018

What global health stories will we tell about 2018? The crystal ball is cloudy, but the haze parted long enough for us to discern a few things.

As 2018 begins, STAT reporters are taking a look at the stories they’re most eager to track this year. Find all our “three to watch” series here

Some years there’s a single global health story that dominates the headlines, like Ebola in 2014 or Zika in 2016. But 2017 wasn’t one of those years.

There were a number of big stories, and big challenges. A devastating in Yemen. An alarming epidemic of in Madagascar. The spread of in Syria, which paralyzed 74 children who were already struggling to survive the country’s relentless and bloody civil war. On a happier note, the World Health Organization got a, Tedros Adhanom Ghebreyesus of Ethiopia.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Boy Dying In Pfizer Trial; AstraZeneca Yanking Covid Shot, And More
A young boy died in a clinical trial for an experimental Pfizer gene therapy for Duchenne muscular dystrophy, about a year after receiving the therapy.

Related Books & Audiobooks